Tc-99m Depreotide Detecting Malignant Pulmonary Nodules: Histopathologic Correlation with Semiquantitative Tumor-to-Normal Lung Ratio

Clinical Nuclear Medicine

Volumn 29, Issue 3, 2004, Pages 171-176

  Shih, Wei Jen ^a   Samayoa, Luis ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adenocarcinoma; Large cell carcinoma; Pulmonary nodule; Squamous cell carcinoma; Tc 99m depreotide; Tumor to normal lung ratio

Indexed keywords

DEPREOTIDE TC 99M; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG TISSUE LEVEL; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NODULE; LUNG SQUAMOUS CELL CARCINOMA; MALE; PREDICTION; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION; TUMOR VOLUME;

AGED; CARCINOMA; COIN LESION, PULMONARY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1542377495     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000113855.93504.03     Document Type: Article

References (13)

1. Blum JE, Handmaker H, Rinne NA. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest. 1999;115:224-232.
2. Blum J, Handmaker H, Lister-James J, et al. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Chest. 2000;117:1232-1238.
3. Kemstine KH, Kahn D, Menda Y, et al. A new technique for staging potentially-resectable lung cancer: Neotec SPECT Tc-99m (NeoTec) compared with F-18 FDG. American Society of Clinical Program/Proceedings; 2001;20:339a.
4. Montilla JL, Bridwell RS. Average vs maximal count region of interest quantitative analysis of lung nodules using Tc-99m depreotide. Is this nodule malignant? J Nucl Med. 2002;43:3-5.
5. Zucker RJ, Bradley YC. Semi-quantitative NecoTect® scintigraphy the new gold standard for solitary pulmonary nodules? Radiology. 2002; 228:Suppl:564.
6. Vallabhajosula S, Moyer BR, Lister-James J, et al. Preclinical evaluation of Tc-99m labeled somatostatin receptor-binding peptides. J Nucl Med. 1996;37:1066-1022.
7. Virgolini I, Leimer M, Handmaker H, et al. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, Tc-99m-P829. Cancer Res. 1998;58:1850-1859.
8. Morehead RS, Shih WJ. Tc-99m labeled somatostatin receptor-binding peptide imaging for a pulmonary nodule. Clin Nucl Med. 2001;26:910-912.
9. Miliziano JS, Bradley YC. Soft tissue metastases and lung cancer recurrences detected by Tc-99m depreotide scintigraphy. Clin Nucl Med. 2002;27:410-412.
10. Montilla-Soler JL, Bridwell RS. Tc-99m depreotide scintigraphy of breast carcinoma. Clin Nucl Med. 2002;27:202-204.
11. Vikic-Topic S, Raisch KP, Kvols LK. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab. 1995;80:2974-2979.
12. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer. 1994;56:681-688.
13. Reubi JC, Schaer JC, Laissue JA, et al. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism. 1996;45 (suppl):39-41.